Skip to Content

Medlst MBS Ttl Rtn Inst SEMMX Fund Analysis

| Medalist Rating as of | See Medalist Partner Investment Hub

Morningstar’s Analysis SEMMX

Will SEMMX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Medlst MBS Ttl Rtn Inst's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor